期刊文献+

首诊乙肝相关原发性肝癌肝外转移危险因素分析 被引量:3

Risk factors for extrahepatic metastasis of hepatitis B-related hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨首诊时影响乙肝相关原发性肝癌肝外转移的危险因素。方法收集2016年1月至2017年10月资料完整的乙肝相关肝癌患者178例。根据有无肝外转移分为肝外转移组和无肝外转移组,比较两组患者首诊时的临床资料,并采用logistic回归分析乙肝相关原发性肝癌肝外转移的危险因素。结果178例患者中无肝外转移组147例,肝外转移组31例。肝外转移组与无肝外转移组患者的肿瘤大小、肿瘤个数、血管侵犯、肝功能Child-Pugh分级、甲胎蛋白比较差异均有统计学意义(均P<0.05)。多因素分析显示,肿瘤大小(OR=5.521,95%CI:1.410~21.613,P=0.014)、肿瘤个数(OR=1.882,95%CI:1.049~3.379,P=0.034)为乙肝相关原发性肝癌肝外转移的危险因素。结论乙肝相关原发性肝癌肝外转移与血管侵犯、Child-Pugh分级、肿瘤个数、肿瘤大小、甲胎蛋白有相关性,肿瘤大小及肿瘤个数为其独立危险因素,有助于首诊时对是否已发生转移作出判断。 Objective To investigate the risk factors of extrahepatic metastasis of hepatitis B-related hepatocellular carcinoma.Methods A retrospective analysis was conducted among patients with hepatitis B-related hepatocellular carcinoma who were diagnosed in Xixi Hospital from January 2016 to October 2017.The risk factors were analyzed byχ2 test,t test and logistic regression.Results A total of 178 patients with hepatitis B-related hepatocellular carcinoma were enrolled.There were 147 cases without extrahepatic metastasis and 31 cases with extrahepatic metastasis.Extrahepatic metastasis was associated with vascular invasion,Child-Pugh classification,number of tumors,size of tumors andα-fetoprotein level.Multivariate analysis showed that tumor size(P=0.014,95%CI:1.410~21.613,OR=5.521)and number of tumors(P=0.034,95%CI:1.049~3.379,OR=1.882)were independent risk factors for extrahepatic metastasis of hepatitis B-related hepatocellular carcinoma.Conclusion Extrahepatic metastasis of hepatitis B-related hepatocellular carcinoma is correlated with vascular invasion,Child-Pugh classification,number of tumors,size of tumors and alpha-fetoprotein.The size of tumors and number of tumors are independent risk factors.
作者 张晓敏 余吉仙 ZHANG Xiaomin;YU Jixian(Department of Oncology,Xixi Hospital of Hangzhou,Hangzhou 310012,China)
出处 《浙江医学》 CAS 2019年第22期2413-2416,共4页 Zhejiang Medical Journal
关键词 乙肝 原发性肝癌 肝外转移 危险因素 Hepatitis B Hepatocellular carcinoma Extrahepatic metastasis Risk factors
  • 相关文献

参考文献1

二级参考文献40

  • 1Shin JW, Chung YH. Molecular targeted therapy for hepatocellularcarcinoma: current and future. World J Gastroenterol 2013; 19:6144-6155 [PMID: 24115810 DOI: 10.3748/wjg.v19.i37.6144].
  • 2El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-1127 [PMID: 21992124 DOI: 10.1056/NEJMra1001683].
  • 3Forner A, Reig ME, de Lope CR, Bruix J. Current strategy forstaging and treatment: the BCLC update and future prospects Semin Liver Dis 2010; 30: 61-74 [PMID: 20175034 DOI: 10.1055/s-0030-1247133].
  • 4Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, EndoY, Nagataki S. Early recognition of hepatocellular carcinoma basedon altered profiles of alpha-fetoprotein. N Engl J Med 1993; 328:1802-1806 [PMID: 7684823].
  • 5Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen TF, Wang WT,Xu MQ, Yang JY. Value of α-fetoprotein in association withclinicopathological features of hepatocellular carcinoma. World JGastroenterol 2013; 19: 1811-1819 [PMID: 23555170 DOI: 10.3748/wjg.v19.i11.1811].
  • 6Palka J, Surazynski A, Karna E, Orlowski K, Puchalski Z, PruszynskiK, Laszkiewicz J, Dzienis H. Prolidase activity disregulation inchronic pancreatitis and pancreatic cancer. Hepatogastroenterology2002; 49: 1699-1703 [PMID: 12397770].
  • 7Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependentregulation of collagen biosynthesis. Amino Acids 2008; 35: 731-738[PMID: 18320291 DOI: 10.1007/s00726-008-0051-8].
  • 8Nicolson GL, Poste G. Tumor cell diversity and host responses incancer metastasis--part II--host immune responses and therapy ofmetastases. Curr Probl Cancer 1983; 7: 1-42 [PMID: 6340978].
  • 9Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, WernertN, Moro D, Brambilla C, Brambilla E. Expression of c-ets-1,collagenase 1, and urokinase-type plasminogen activator genesin lung carcinomas. Am J Pathol 1995; 147: 1298-1310 [PMID:7485393].
  • 10Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis,staging, and treatment of hepatocellular carcinoma. Liver Transpl2004; 10: S115-S120 [PMID: 14762851].

共引文献7

同被引文献32

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部